Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Sabien Shares Fall On Ptarmigan Health Acquisition Withdrawal

Wed, 20th Jan 2021 13:14

(Alliance News) - Shares in Sabien Technology Group PLC plunged on Wednesday as it announced that its GBP11.5 million acquisition of Swiss-based health destination firm Ptarmigan Health Destinations would not be going through.

Shares in the energy efficiency technology firm were restored to trading on Wednesday after being suspended last January, and were down 45% at 0.10 pence.

The reason for the withdrawal was that Sabien would not have been able to secure the required approval from Swiss and UK regulators in enough time to avoid its shares being cancelled on AIM.

As a result of this, Sabien said it requires further financing in the short-term in order to invest in itself as well as bolster working capital. Therefore the company has issued convertible unsecured loan notes through its broker Peterhouse Capital Ltd to raise GBP1.3 million.

In addition, Sabien will issue 2.50 billion warrants to subscribe for shares at a price of 0.1 pence per warrant. They will be granted to holders of the notes and can be exercised until January 19, 2022.

However, the group said it does not have authority to enable the full conversion of the notes or the placing warrants. Therefore Sabien will convene a general meeting in which it will propose being granted authority to allow for the conversion of notes and warrants.

"Whilst it is disappointing to have to withdraw from the proposed acquisition, I believe that shareholders will benefit from the restoration of Sabien's shares to trading and the impact which the convertible loan note issue will have on the continued development of the company's green technology," said Chair Richard Parris.

"The experience of the pandemic to date has shown that governments around the world are fully focused on a greener agenda. It is my belief that Sabien will contribute to the accelerated work towards a carbon neutral economy and that shareholders will benefit from this contribution," Parris added.

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
19 Feb 2024 11:32

Sabien Technology interim loss narrows; confident in future

(Alliance News) - Sabien Technology Group PLC on Monday said it demonstrated the ability to scale and scope its developments as it reported a narrowed...

7 Feb 2024 13:17

Sabien gas-saving tech installed at Hampton Court Palace

(Sharecast News) - Sabien Technology Group announced the installation of its M2G Cloud Connect system at Hampton Court Palace on Wednesday.

7 Feb 2024 11:30

Sabien Technology installs M2G Cloud Connect system at Hampton Court

(Alliance News) - Sabien Technology Group PLC on Wednesday said its gas boiler energy saving solutions arm M2G has installed its Cloud Connect system ...

9 Jan 2024 12:59

Sabien flags decent first-half growth

(Sharecast News) - Sabien Technology said in an update on Tuesday that in its first half, its cloud-enabled gas boiler energy-saving solution, M2G, de...

29 Nov 2023 11:26

IN BRIEF: Sabien Technology rises on higher demand for M2G

Sabien Technology Group PLC - London-based company focused on green technologies such as plastic-to-oil recycling and CO2 mitigation for commercial an...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.